Michael Mencher

Michael represents public and late-stage private life sciences and technology companies in a broad range of corporate matters, with an emphasis on corporate governance and SEC reporting advice. He counsels public companies and their boards on securities regulation and governance issues, including Exchange Act reporting, annual meetings, shareholder activism, insider trading, and board structure and composition matters. Michael also advises companies on environmental, social, and governance (ESG) matters, including sustainability reporting, board oversight and disclosure controls, and shareholder and stakeholder engagement. Michael regularly assists IPO and deSPAC companies on public company readiness matters, and he works closely with newly public companies on their initial SEC reporting and establishing key governance and SEC compliance processes. In addition, he has extensive experience representing public companies in various securities offerings, such as IPOs, registered debt and equity offerings, private investment in public equity (PIPE) deals, and sustainable finance transactions.